Merck & Co., Inc.
- SEC CIK
- 0000310158
- Latest filing
- Aug 7, 2026
Holdings in Q2 2025
Holdings as of Jun 30, 2025, filed Aug 13, 2025. Long positions only; changes compare share counts with Q1 2025.
- Positions
- 13
- +1 vs. Q1 2025
- Portfolio value
- $215.6M
- +$51.3M (+31.2%) vs. Q1 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PSNLPersonalis, Inc. | COM | 14,044,943 | $92.1M | 42.7% | 00.0% | Unchanged | History |
| MRNAModerna, Inc. | Stock | 2,308,190 | $63.7M | 29.5% | 00.0% | Unchanged | History |
| KYMRKymera Therapeutics, Inc. | COM | 772,165 | $33.7M | 15.6% | 00.0% | Unchanged | History |
| Entrada Therapeutics Inc29384C908 | CALL | 1,739,768 | $11.7M | 5.4% | 00.0% | Unchanged | – |
| ALECAlector, Inc. | COM | 3,545,719 | $4.96M | 2.3% | 00.0% | Unchanged | History |
| EVAXEvaxion A/S | COM | 1,214,126 | $2.97M | 1.4% | 00.0% | Unchanged | History |
| STROSutro Biopharma, Inc. | COM | 2,723,509 | $1.94M | 0.9% | 00.0% | Unchanged | History |
| LVTXLAVA Therapeutics NV | SHS | 1,149,345 | $1.52M | 0.7% | 00.0% | Unchanged | History |
| VRDNViridian Therapeutics, Inc. | COM | 93,414 | $1.31M | 0.6% | 00.0% | Unchanged | History |
| XLOXilio Therapeutics, Inc. | COM | 1,483,758 | $1.01M | 0.5% | 00.0% | Unchanged | History |
| CARMCarisma Therapeutics Inc. | COM | 1,473,240 | $576.9K | 0.3% | 00.0% | Unchanged | History |
| NEUPNeuphoria Therapeutics Inc. | COM | 10,027 | $71.2K | <0.1% | 00.0% | Unchanged | History |
| HURATuHURA Biosciences, Inc. | COM | 13,950 | $31.1K | <0.1% | +13,950 | New | History |